Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Comment
  • Published:

Transporters in drug development: advancing on the Critical Path

Nature Reviews Drug Discovery volume 9, pages 175–176 (2010)Cite this article

Subjects

Abstract

A new report from an international consortium provides comprehensive scientific recommendations for studies of transporter-related drug interactions in drug development.

This is a preview of subscription content, access via your institution

Access options

Buy this article

  • Purchase on Springer Link
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

References

  1. US Department of Health and Human Services, Food and Drug Administration. US FDA website [online], (2004).

  2. Giacomini, K. M. et al. Nature Rev. Drug Discov. 9, 215–236 (2010).

    Article  CAS  Google Scholar 

  3. Qato, D. M. et al. JAMA 300, 2867–2878 (2008).

    Article  CAS  Google Scholar 

  4. Schmassmann-Suhijar, D. et al. Lancet 351, 1929–1930 (1998).

    Article  CAS  Google Scholar 

  5. Link, E. et al. N. Engl. J. Med. 359, 789–799 (2008).

    Article  CAS  Google Scholar 

  6. US Food and Drug Administration. US FDA website [online], (2009).

  7. US Department of Health and Human Services, Food and Drug Administration, Center for Drug Evaluation and Research (CDER). US FDA website, [online], (2010).

  8. US Food and Drug Administration. US FDA website [online], (2009).

Download references

Acknowledgements

The authors acknowledge K. Giacomini for helpful discussions.

Author information

Authors and Affiliations

  1. Shiew-Mei Huang is at the Office of Clinical Pharmacology, Office of Translational Sciences, Center for Drug Evaluation and Research, Food and Drug Administration, 10903 New Hampshire Avenue, Silver Spring, Maryland 20993-0002, USA.,

    Shiew-Mei Huang

  2. Janet Woodcock is Director of the Center for Drug Evaluation and Research, Food and Drug Administration.,

    Janet Woodcock

Authors
  1. Shiew-Mei Huang
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Janet Woodcock
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Janet Woodcock.

Ethics declarations

Competing interests

The authors declare no competing financial interests.

Supplementary information

Supplementary information S1 (box)

FDA information sources related to drug–drug interactions (PDF 222 kb)

Rights and permissions

Reprints and permissions

About this article

Cite this article

Huang, SM., Woodcock, J. Transporters in drug development: advancing on the Critical Path. Nat Rev Drug Discov 9, 175–176 (2010). https://doi.org/10.1038/nrd3124

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1038/nrd3124

This article is cited by

Search

Advanced search

Quick links

Nature Briefing: Translational Research

Sign up for the Nature Briefing: Translational Research newsletter — top stories in biotechnology, drug discovery and pharma.

Get what matters in translational research, free to your inbox weekly. Sign up for Nature Briefing: Translational Research